Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-5-3
|
pubmed:keyword | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0003-2409
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
171
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2564748-Anti-Anxiety Agents,
pubmed-meshheading:2564748-Anxiety,
pubmed-meshheading:2564748-Clinical Trials as Topic,
pubmed-meshheading:2564748-Humans,
pubmed-meshheading:2564748-Informed Consent,
pubmed-meshheading:2564748-Preanesthetic Medication,
pubmed-meshheading:2564748-Research Subjects,
pubmed-meshheading:2564748-Therapeutic Human Experimentation
|
pubmed:year |
1989
|
pubmed:articleTitle |
Anxiety and informed consent.
|
pubmed:publicationType |
Letter,
Clinical Trial
|